Presentation of Primary Polycythemia (Polycythemia Vera)
Primary polycythemia (polycythemia vera) typically presents with elevated hemoglobin/hematocrit (>16.5 g/dL in men, >16.0 g/dL in women), often accompanied by thrombocytosis (53% of patients) and leukocytosis (49%), along with characteristic symptoms including aquagenic pruritus (48%), splenomegaly (36%), erythromelalgia (3-5.3%), headache, and visual disturbances. 1, 2
Hematologic Features
The cardinal laboratory finding is erythrocytosis, which is a required diagnostic criterion 3, 2:
- Hemoglobin >16.5 g/dL (hematocrit >49%) in men
- Hemoglobin >16.0 g/dL (hematocrit >48%) in women
Additional blood count abnormalities commonly include:
- Thrombocytosis (present in 53% of patients) 2
- Leukocytosis (present in 49% of patients) 2
- Microcytosis from iron deficiency (due to phlebotomy or occult bleeding) 1
Clinical Symptoms and Signs
Microvascular Disturbances
These result from platelet-endothelial interactions causing transient occlusive phenomena 1:
- Headache and light-headedness
- Transient neurologic or ocular disturbances (14% have visual changes) 2
- Tinnitus
- Atypical chest discomfort
- Paresthesias
- Erythromelalgia (3-5.3%): painful burning sensation of feet/hands with erythema and warmth, responds dramatically to low-dose aspirin within hours 1, 2
Pruritus
Generalized pruritus exacerbated by hot baths is a characteristic feature, documented in 48% of patients either at diagnosis or later 1. This can be the most debilitating symptom, causing sleep deprivation and interference with daily activities 1.
Physical Examination Findings
- Splenomegaly (36% of patients) with associated abdominal discomfort 2
- Plethora (ruddy complexion, engorged veins) 1
Thrombotic and Hemorrhagic Complications
Thromboembolism is the most important complication 4:
- Arterial thrombosis occurs in 16% prior to or at diagnosis 2
- Venous thrombosis in 7%, often in unusual sites like splanchnic veins (Budd-Chiari syndrome) 1, 2
- Increased bleeding risk, especially with extreme thrombocytosis (platelet count ≥1000 × 10⁹/L) due to acquired von Willebrand disease 2
Molecular and Laboratory Markers
More than 95% of patients harbor JAK2 mutations 3, 4, 2:
Serum erythropoietin levels are characteristically low or low-normal (specificity >90%, but sensitivity <70%) 1. A high serum EPO level essentially excludes PV and suggests secondary polycythemia 1.
Bone Marrow Findings
Characteristic morphologic changes include 1:
- Hypercellularity (panmyelosis)
- Increased megakaryocytes with cluster formation
- Giant megakaryocytes with pleomorphism
- Mild reticulin fibrosis (12% at diagnosis)
- Decreased bone marrow iron stores
Constitutional Symptoms
Patients may experience 5:
- Fatigue
- Night sweats
- Weight loss
- Fever
These constitutional symptoms are more prominent when disease progresses toward myelofibrosis 5.
Important Clinical Pitfalls
A common diagnostic error is missing PV in patients with upper-normal hematocrit who have other PV-related features (thrombocytosis, leukocytosis, microcytosis, splenomegaly, aquagenic pruritus, unusual thrombosis, erythromelalgia) 1. In such cases, the diagnosis should be actively pursued with serum EPO levels and bone marrow examination, regardless of the hematocrit value 1.
Iron deficiency from chronic phlebotomy or occult bleeding can mask the true degree of erythrocytosis, presenting with microcytosis and a deceptively lower hematocrit 1.
Age and Epidemiology
PV is most prevalent in the seventh decade of life, with a male-to-female ratio of 1.5:1 5. However, the disease can occur at any age, and younger patients (≤40 years) have significantly better survival exceeding 35 years 6.